- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7056 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
Patent holdings for IPC class A61K 31/7056
Total number of patents in this class: 1241
10-year publication summary
|
99
|
99
|
86
|
91
|
76
|
116
|
85
|
78
|
68
|
62
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2094 |
45 |
| Galecto Biotech AB | 73 |
34 |
| Boehringer Ingelheim Vetmedica GmbH | 1275 |
30 |
| Takeda Pharmaceutical Company Limited | 2717 |
21 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
17 |
| Vertex Pharmaceuticals Incorporated | 1628 |
16 |
| Bausch Health Ireland Limited | 801 |
16 |
| Centre National de La Recherche Scientifique | 10693 |
15 |
| Boehringer Ingelheim International GmbH | 4635 |
14 |
| President and Fellows of Harvard College | 6036 |
14 |
| Bristol-myers Squibb Company | 4820 |
13 |
| GlycoMimetics, Inc. | 122 |
13 |
| Novartis AG | 10623 |
10 |
| Merck Sharp & Dohme Corp. | 2190 |
9 |
| Alectos Therapeutics Inc. | 48 |
8 |
| Cmpd Licensing, LLC | 81 |
8 |
| Enanta Pharmaceuticals, Inc. | 434 |
8 |
| Idenix Pharmaceuticals LLC | 61 |
8 |
| Curology, Inc. | 72 |
8 |
| Merck Sharp & Dohme LLC | 3737 |
8 |
| Other owners | 926 |